Solta Medical expects to report fourth quarter and full year 2012 financial results on February 19, 2013.
Raymond James & Associates, Inc. served as exclusive financial advisor to Solta Medical and William Blair & Company, LLC served as exclusive financial advisor to Sound Surgical in this transaction.
Conference Call Information The company will also host a conference call and webcast today, Tuesday, January 29, 2013, at 6:00 p.m. Eastern Time ( 3:00 p.m. Pacific) to discuss the acquisition and current corporate developments. The dial-in number for the conference call is 800-762-8779 for domestic participants and 480-629-9645 for international participants.
To access the live webcast of the call, go to Solta Medical's website at www.solta.com and click on Investor Relations. A slide presentation will accompany the call and webcast. It too can be found on the investor relations page of the company's website at solta.com. An archived webcast will also be available at www.solta.com.Non-GAAP PresentationTo supplement the condensed consolidated financial information presented on a GAAP basis, management has provided non-GAAP gross margin and non-GAAP operating income measures that exclude amortization and other acquisition related charges, non-cash stock based compensation charges, and charges for the fair value reassessment of acquisition related contingent liabilities. The company believes that these non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of the company's ongoing operating results and trends, compared with historical results. This presentation is also consistent with the measures management uses to measure the performance of ongoing operating results against prior periods and against our internally developed targets. There are limitations in using these non-GAAP financial measures because they are not prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. These non-GAAP financial measures should not be considered in isolation or as a substitute for GAAP financial measures. About Solta Medical, Inc.Solta Medical, Inc. is a global leader in the medical aesthetics market providing innovative, safe, and effective solutions for patients that enhance and expand the practice of medical aesthetics for physicians. The company offers six aesthetic energy devices to address a range of issues, including skin resurfacing and rejuvenation with Fraxel® and Clear + Brilliant(TM), body contouring and skin tightening with Liposonix® and Thermage® and acne reduction with Isolaz® and CLARO(TM). As the innovator and leader in fractional laser technology, Fraxel delivers minimally invasive clinical solutions to resurface aging and sun damaged skin. Using similar fractional laser technology, Clear + Brilliant is a unique, cost-effective treatment to prevent and improve the early signs of photoaging. For body contouring, Liposonix is a non-surgical treatment to reduce waist circumference with advanced high-intensity focused ultrasound (HIFU) technology to permanently destroy targeted fat beneath the skin. Thermage is an innovative, non-invasive radiofrequency procedure for tightening and contouring skin. Isolaz was the first laser or light based system indicated for the treatment of inflammatory acne, comedonal acne, pustular acne, and mild-to-moderate inflammatory acne. CLARO is a personal care acne system that is the first FDA cleared over-the-counter IPL device that uses a powerful combination of both heat and light to clear skin quickly and naturally. More than two million procedures have been performed with Solta Medical's portfolio of products around the world. For more information about Solta Medical, call 1-877-782-2286 or log on to www.Solta.com. About Sound Surgical TechnologiesSound Surgical Technologies designs, develops, manufactures and distributes market leading surgical and non-invasive body shaping products that are backed by strong science and clinical efficacy, including the VASER Lipo®, VASER® Shape, PowerX®, TouchView®, Origins™ and VASERsmooth™ product lines. The company has been a well-respected and trusted manufacturer of ultrasound-assisted liposuction technology since 1998 and has spent the past two years building out a complete suite of body shaping products designed to serve the aesthetic market. Sound Surgical Technologies designs and builds its products in Louisville, CO and sells the equipment through a direct sales channel in the USA, Canada, United Kingdom, and Ireland and through distributor partners worldwide. For more information on Sound Surgical Technologies and all of the company's product lines, please visit www.SoundSurgical.com. Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Solta Medical's actual results to differ materially from the statements contained herein. Further information on potential risk factors that could affect Solta Medical's business and its financial results are detailed in its Form 10-K for the year ended December 31, 2011, and other reports as filed from time to time with the Securities and Exchange Commission. Forward looking statements include the expectations of the Sound Surgical acquisition being accretive to the company in future periods, the ability to successfully cross-sell products and the anticipated closing date of the transaction, as well as Solta Medical's expected results for the fourth quarter and full year 2012. Undue reliance should not be placed on forward-looking statements, especially guidance on future financial performance, which speaks only as of the date they are made. Solta Medical undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. SOURCE Solta Medical, Inc.